manufacturing practices, permits, governmental licenses, registrations, approvals, authorizations, orders, injunctions and decrees, in the research, development, manufacture and use of any Product, and neither GCLC nor any GCLC Subsidiary has received any written notice from any Governmental Authority claiming that any such activities as conducted by it are not in such compliance.
(h) All of GCLCs and GCLC Subsidiaries employees acting on its behalf who have performed research, development, manufacturing or regulatory activities with respect to any Product are and will be obligated under a binding written agreement to comply with obligations of confidentiality and non-use no less restrictive than those set forth in Article 9 of the Option Agreement.
Notwithstanding the foregoing, any Product Patents licensed or sublicensed under the AbClon Agreement is licensed by GCLC to Artiva and its Affiliates and Sublicensees without any representations or warranties of any kind except for the following: (i) first and second sentences of Section 6.2(a), (ii) first, second and third sentences of Section 6.2(b), but in each case only to GCLCs Knowledge, and (iii) Section 6.2(c), Section 6.2(d), Section 6.2(e) and Section 6.2(f), but in each case only to GCLCs Knowledge.
6.3 Covenants. Each Party covenants to the other Party as follows:
(a) No Debarment. Neither such Party, nor, in the case of GCLC, its GCLC Subsidiaries, is debarred or disqualified under the United States Federal Food, Drug and Cosmetic Act or comparable applicable Laws in the Territory and, in the course of development, manufacturing or other activities relating to any Product, neither Party, nor, in the case of GCLC, its GCLC Subsidiaries, has used or shall use any employee, consultant or subcontractor who has been debarred or disqualified or, to such Partys Knowledge, is the subject of debarment or disqualification proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its or its Subsidiaries employees, consultants or subcontractors involved in any development, manufacturing or other activities relating to any Product has been debarred or disqualified or is the subject of debarment or disqualification proceedings by any Regulatory Authority.
(b) Compliance. Both Parties and their respective Affiliates shall comply in all material respects with all applicable Laws in the development, manufacture and commercialization of any Product, in each case, to the extent applicable, including the statutes, regulations and written directives of the FDA, the EMA and any other Regulatory Authorities, the Federal Food, Drug & Cosmetic Act, as amended, the Prescription Drug Marketing Act, the Federal Health Care Programs Anti-Kickback Law, 42 U.S.C. 1320a-7b(b), the statutes, regulations and written directives of Medicare, Medicaid and all other health care programs, as defined in 42 U.S.C. § 1320a-7b(f), and the Foreign Corrupt Practices Act of 1977, each as may be amended from time to time.
(c) Employees and Subcontractors. During the Term, all employees and subcontractors of a Party or its Affiliates performing research, development, commercialization or other activities contemplated hereunder on behalf of such Party or its Affiliates shall be obligated